View of Omalizumab for treatment of refractory urticaria in a patient with metastatic uveal melanoma receiving tebentafusp

Return to Article Details Omalizumab for treatment of refractory urticaria in a patient with metastatic uveal melanoma receiving tebentafusp Download Download PDF